Gene Symbol | Gene ID | Gene Info |
---|---|---|
Irx6
|
ENSMUSG00000031738.8 | Iroquois homeobox 6 |
Irx2
|
ENSMUSG00000001504.9 | Iroquois homeobox 2 |
Irx3
|
ENSMUSG00000031734.11 | Iroquois related homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_72628045_72629655 | Irx2 | 30 | 0.804264 | -0.51 | 3.7e-05 | Click! |
chr13_72629730_72632045 | Irx2 | 1062 | 0.509200 | -0.40 | 1.4e-03 | Click! |
chr13_72638289_72638999 | Irx2 | 6047 | 0.219362 | -0.40 | 1.5e-03 | Click! |
chr13_72636298_72636937 | Irx2 | 4020 | 0.242501 | -0.36 | 5.3e-03 | Click! |
chr13_72632318_72633242 | Irx2 | 183 | 0.951295 | -0.31 | 1.7e-02 | Click! |
chr8_91800429_91802211 | Irx3 | 595 | 0.517494 | -0.50 | 4.1e-05 | Click! |
chr8_92673364_92674896 | Irx6 | 158 | 0.956425 | -0.68 | 2.4e-09 | Click! |
chr8_92677787_92678860 | Irx6 | 3497 | 0.226162 | -0.67 | 4.3e-09 | Click! |
chr8_92677167_92677608 | Irx6 | 2561 | 0.270133 | -0.43 | 5.3e-04 | Click! |
chr8_92675786_92676331 | Irx6 | 1232 | 0.468447 | -0.32 | 1.1e-02 | Click! |
chr8_92670285_92670932 | Irx6 | 3680 | 0.238245 | -0.22 | 9.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_115819043_115819440 | 13.76 |
Tspan8 |
tetraspanin 8 |
1957 |
0.43 |
chr7_115845489_115845805 | 13.57 |
Sox6 |
SRY (sex determining region Y)-box 6 |
458 |
0.89 |
chr9_120116040_120116439 | 12.00 |
Slc25a38 |
solute carrier family 25, member 38 |
1250 |
0.23 |
chr2_109283733_109283884 | 10.28 |
Kif18a |
kinesin family member 18A |
2939 |
0.28 |
chr11_11687647_11688276 | 9.56 |
Ikzf1 |
IKAROS family zinc finger 1 |
1516 |
0.33 |
chr17_48450856_48451498 | 9.12 |
Tspo2 |
translocator protein 2 |
315 |
0.83 |
chr17_12378732_12379615 | 8.92 |
Plg |
plasminogen |
514 |
0.75 |
chr10_115817324_115818606 | 8.80 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr12_99457193_99458078 | 8.79 |
Foxn3 |
forkhead box N3 |
7538 |
0.2 |
chr3_127893429_127894301 | 8.72 |
Fam241a |
family with sequence similarity 241, member A |
2423 |
0.2 |
chr3_60472420_60472995 | 8.62 |
Mbnl1 |
muscleblind like splicing factor 1 |
123 |
0.98 |
chr3_135827808_135828432 | 8.49 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
2030 |
0.27 |
chr14_55061871_55064122 | 8.43 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr19_43783410_43784001 | 8.43 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
1379 |
0.35 |
chr14_118796451_118797209 | 8.36 |
Cldn10 |
claudin 10 |
8912 |
0.16 |
chr17_40813775_40814352 | 8.07 |
Rhag |
Rhesus blood group-associated A glycoprotein |
2879 |
0.21 |
chr5_134913789_134913940 | 8.04 |
Cldn13 |
claudin 13 |
1662 |
0.18 |
chr1_71100990_71101619 | 7.86 |
Bard1 |
BRCA1 associated RING domain 1 |
1842 |
0.43 |
chr5_117133717_117134877 | 7.57 |
Taok3 |
TAO kinase 3 |
656 |
0.62 |
chr4_13754294_13755025 | 7.06 |
Runx1t1 |
RUNX1 translocation partner 1 |
3362 |
0.37 |
chr9_75168312_75168603 | 6.99 |
Myo5a |
myosin VA |
15727 |
0.16 |
chr6_83352288_83352454 | 6.94 |
Bola3 |
bolA-like 3 (E. coli) |
276 |
0.86 |
chr8_104962508_104963341 | 6.94 |
Ces2g |
carboxylesterase 2G |
1149 |
0.31 |
chr11_31876349_31876576 | 6.76 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
3187 |
0.27 |
chr4_154911979_154912466 | 6.69 |
Prxl2b |
peroxiredoxin like 2B |
13087 |
0.11 |
chr15_83423223_83423670 | 6.68 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
344 |
0.85 |
chr2_170150859_170151260 | 6.61 |
Zfp217 |
zinc finger protein 217 |
2956 |
0.37 |
chr5_31685790_31686074 | 6.55 |
Rbks |
ribokinase |
161 |
0.93 |
chr5_64810297_64813272 | 6.50 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr16_17331632_17331929 | 6.41 |
Serpind1 |
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
397 |
0.77 |
chr17_36019993_36020160 | 6.30 |
H2-T24 |
histocompatibility 2, T region locus 24 |
449 |
0.55 |
chr4_87804582_87805116 | 6.28 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
1445 |
0.57 |
chr12_57195678_57195869 | 6.27 |
Slc25a21 |
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 |
1699 |
0.39 |
chr10_62341499_62342686 | 6.27 |
Hk1 |
hexokinase 1 |
607 |
0.63 |
chr5_115946520_115947438 | 6.14 |
Cit |
citron |
1682 |
0.33 |
chr3_60475122_60475415 | 6.01 |
Mbnl1 |
muscleblind like splicing factor 1 |
2189 |
0.39 |
chr6_5153930_5154226 | 5.97 |
Pon1 |
paraoxonase 1 |
39685 |
0.14 |
chr14_66999338_66999780 | 5.96 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
98 |
0.96 |
chr11_69915606_69917001 | 5.92 |
Gps2 |
G protein pathway suppressor 2 |
262 |
0.72 |
chr8_60981385_60981536 | 5.92 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
1779 |
0.25 |
chr3_116860395_116860804 | 5.66 |
Frrs1 |
ferric-chelate reductase 1 |
1032 |
0.41 |
chr3_83048284_83048966 | 5.63 |
Fgb |
fibrinogen beta chain |
1238 |
0.39 |
chr15_30285819_30286500 | 5.54 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
113021 |
0.06 |
chr12_78912556_78912749 | 5.50 |
Plek2 |
pleckstrin 2 |
5688 |
0.2 |
chr11_102360845_102363484 | 5.48 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr2_151037302_151037453 | 5.35 |
Nanp |
N-acetylneuraminic acid phosphatase |
1985 |
0.19 |
chr11_82868787_82869208 | 5.35 |
Rffl |
ring finger and FYVE like domain containing protein |
1747 |
0.21 |
chr11_74622615_74622882 | 5.33 |
Ccdc92b |
coiled-coil domain containing 92B |
3143 |
0.21 |
chr7_75612178_75613652 | 5.30 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr11_31874060_31874636 | 5.27 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
1073 |
0.55 |
chr16_58675826_58676599 | 5.27 |
Cpox |
coproporphyrinogen oxidase |
1627 |
0.28 |
chr6_60826003_60826617 | 5.26 |
Snca |
synuclein, alpha |
1246 |
0.48 |
chr16_77597699_77598173 | 5.22 |
Mir99a |
microRNA 99a |
1000 |
0.31 |
chr2_43748681_43749054 | 5.21 |
Arhgap15 |
Rho GTPase activating protein 15 |
2 |
0.99 |
chr11_97439854_97442222 | 5.21 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr11_32285664_32285820 | 5.21 |
Hbq1b |
hemoglobin, theta 1B |
1223 |
0.27 |
chr11_11688536_11688696 | 5.18 |
Ikzf1 |
IKAROS family zinc finger 1 |
2171 |
0.25 |
chr6_58648347_58648799 | 5.15 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
7991 |
0.23 |
chr1_160306011_160306162 | 5.12 |
Rabgap1l |
RAB GTPase activating protein 1-like |
1253 |
0.36 |
chr17_14257300_14257541 | 5.09 |
Gm34567 |
predicted gene, 34567 |
7569 |
0.19 |
chr14_70704541_70705363 | 5.08 |
Xpo7 |
exportin 7 |
3083 |
0.2 |
chr16_32612172_32612323 | 5.07 |
Tfrc |
transferrin receptor |
2985 |
0.19 |
chr4_87804296_87804447 | 5.07 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
1923 |
0.48 |
chr9_78104831_78105183 | 5.05 |
Fbxo9 |
f-box protein 9 |
3580 |
0.15 |
chr18_62178016_62178230 | 5.02 |
Adrb2 |
adrenergic receptor, beta 2 |
1836 |
0.3 |
chr15_97361270_97362062 | 4.97 |
Pced1b |
PC-esterase domain containing 1B |
449 |
0.88 |
chr11_80078564_80079032 | 4.93 |
Crlf3 |
cytokine receptor-like factor 3 |
2063 |
0.27 |
chr14_87140021_87140177 | 4.91 |
Diaph3 |
diaphanous related formin 3 |
1044 |
0.58 |
chrX_85616079_85616575 | 4.89 |
Gm44378 |
predicted gene, 44378 |
27350 |
0.18 |
chr4_123286782_123287699 | 4.86 |
Gm25788 |
predicted gene, 25788 |
4104 |
0.11 |
chr6_136855492_136855648 | 4.85 |
Art4 |
ADP-ribosyltransferase 4 |
2163 |
0.16 |
chr9_103286971_103287430 | 4.82 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
1024 |
0.5 |
chr13_52584600_52584777 | 4.82 |
Syk |
spleen tyrosine kinase |
1185 |
0.6 |
chrX_85613609_85614890 | 4.82 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chr19_45445658_45446098 | 4.80 |
Btrc |
beta-transducin repeat containing protein |
370 |
0.86 |
chr12_78904719_78905643 | 4.78 |
Plek2 |
pleckstrin 2 |
1783 |
0.34 |
chr19_39739833_39740541 | 4.76 |
Cyp2c68 |
cytochrome P450, family 2, subfamily c, polypeptide 68 |
867 |
0.69 |
chr9_66352035_66352703 | 4.76 |
Herc1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
1843 |
0.35 |
chr11_109614897_109615494 | 4.76 |
Gm11685 |
predicted gene 11685 |
1125 |
0.43 |
chr6_38342777_38343261 | 4.75 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
11254 |
0.13 |
chr1_132387629_132389330 | 4.73 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
1839 |
0.25 |
chr10_40132010_40132339 | 4.73 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
10080 |
0.14 |
chr1_37478065_37479166 | 4.73 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9990 |
0.14 |
chr3_127931525_127931952 | 4.71 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
15566 |
0.14 |
chr10_87522427_87522935 | 4.70 |
Pah |
phenylalanine hydroxylase |
654 |
0.72 |
chr5_87002030_87002203 | 4.69 |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
1256 |
0.29 |
chr8_80499828_80500092 | 4.69 |
Gypa |
glycophorin A |
6179 |
0.24 |
chr11_99225962_99226233 | 4.68 |
Smarce1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
4316 |
0.16 |
chr7_133702853_133703004 | 4.67 |
Uros |
uroporphyrinogen III synthase |
312 |
0.83 |
chr6_58645609_58645857 | 4.64 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
5151 |
0.25 |
chr6_23131347_23131655 | 4.62 |
Aass |
aminoadipate-semialdehyde synthase |
1415 |
0.36 |
chr6_66271773_66272006 | 4.61 |
Gm31520 |
predicted gene, 31520 |
616 |
0.76 |
chr18_54424419_54424913 | 4.61 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
2371 |
0.37 |
chr3_122246600_122246914 | 4.61 |
Gclm |
glutamate-cysteine ligase, modifier subunit |
676 |
0.5 |
chr9_43099922_43100283 | 4.61 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
5384 |
0.2 |
chr2_65164079_65164448 | 4.59 |
Cobll1 |
Cobl-like 1 |
58404 |
0.12 |
chr3_65954778_65955426 | 4.58 |
Ccnl1 |
cyclin L1 |
1754 |
0.22 |
chr7_107596387_107596575 | 4.57 |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
1196 |
0.39 |
chr18_68403598_68404095 | 4.57 |
Mc2r |
melanocortin 2 receptor |
25474 |
0.16 |
chr1_40268223_40269018 | 4.57 |
Il1r1 |
interleukin 1 receptor, type I |
1963 |
0.34 |
chr16_18429039_18430122 | 4.55 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chr1_86160457_86160608 | 4.55 |
Armc9 |
armadillo repeat containing 9 |
5713 |
0.14 |
chr11_34048892_34049174 | 4.52 |
Lcp2 |
lymphocyte cytosolic protein 2 |
1865 |
0.37 |
chr1_173332160_173333204 | 4.50 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
820 |
0.54 |
chr11_84867576_84868235 | 4.49 |
Ggnbp2 |
gametogenetin binding protein 2 |
2297 |
0.18 |
chr18_56400322_56401351 | 4.48 |
Gramd3 |
GRAM domain containing 3 |
461 |
0.83 |
chr3_153850391_153850818 | 4.45 |
Asb17os |
ankyrin repeat and SOCS box-containing 17, opposite strand |
1797 |
0.2 |
chr2_163547257_163548345 | 4.44 |
Hnf4a |
hepatic nuclear factor 4, alpha |
613 |
0.63 |
chr3_80686795_80686946 | 4.43 |
Gm25749 |
predicted gene, 25749 |
5443 |
0.32 |
chr13_59819556_59819712 | 4.43 |
Tut7 |
terminal uridylyl transferase 7 |
2954 |
0.14 |
chr5_134228074_134229115 | 4.42 |
Ncf1 |
neutrophil cytosolic factor 1 |
195 |
0.91 |
chr12_105036783_105037593 | 4.42 |
Glrx5 |
glutaredoxin 5 |
1972 |
0.18 |
chr8_80499275_80499705 | 4.41 |
Gypa |
glycophorin A |
5709 |
0.24 |
chr7_143007094_143009025 | 4.41 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr5_117136955_117137730 | 4.39 |
Taok3 |
TAO kinase 3 |
3701 |
0.17 |
chr2_163507247_163507946 | 4.38 |
Hnf4a |
hepatic nuclear factor 4, alpha |
788 |
0.49 |
chr9_108076993_108077144 | 4.38 |
Rnf123 |
ring finger protein 123 |
1201 |
0.2 |
chr18_80257995_80258304 | 4.36 |
Slc66a2 |
solute carrier family 66 member 2 |
1831 |
0.22 |
chr7_28796055_28797204 | 4.34 |
Rinl |
Ras and Rab interactor-like |
309 |
0.76 |
chr15_66811058_66811221 | 4.34 |
Sla |
src-like adaptor |
1454 |
0.42 |
chr5_146599489_146599853 | 4.32 |
Gm34333 |
predicted gene, 34333 |
431 |
0.77 |
chr19_17353278_17353457 | 4.31 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
3300 |
0.29 |
chr6_5292032_5292189 | 4.29 |
Pon2 |
paraoxonase 2 |
3042 |
0.24 |
chr9_108341756_108341907 | 4.28 |
Gpx1 |
glutathione peroxidase 1 |
2555 |
0.11 |
chr12_105034788_105035573 | 4.27 |
Glrx5 |
glutaredoxin 5 |
36 |
0.95 |
chr1_111251149_111251300 | 4.26 |
Gm19927 |
predicted gene, 19927 |
134694 |
0.05 |
chr6_16896833_16897427 | 4.26 |
Tfec |
transcription factor EC |
1269 |
0.53 |
chr5_89456520_89456671 | 4.23 |
Gc |
vitamin D binding protein |
1303 |
0.52 |
chr3_36606072_36606233 | 4.23 |
Bbs7 |
Bardet-Biedl syndrome 7 (human) |
7133 |
0.15 |
chr5_17835023_17835212 | 4.23 |
Cd36 |
CD36 molecule |
579 |
0.85 |
chr12_3285466_3285617 | 4.19 |
Rab10 |
RAB10, member RAS oncogene family |
24428 |
0.14 |
chr2_132575466_132576424 | 4.19 |
Gpcpd1 |
glycerophosphocholine phosphodiesterase 1 |
2188 |
0.27 |
chr3_104642046_104642422 | 4.19 |
Gm43581 |
predicted gene 43581 |
760 |
0.44 |
chr6_129350891_129351188 | 4.18 |
Clec12a |
C-type lectin domain family 12, member a |
1075 |
0.39 |
chr14_69322621_69322921 | 4.17 |
Gm16677 |
predicted gene, 16677 |
14311 |
0.09 |
chrX_169037778_169038469 | 4.17 |
Arhgap6 |
Rho GTPase activating protein 6 |
1512 |
0.52 |
chr1_58969882_58970334 | 4.14 |
Trak2 |
trafficking protein, kinesin binding 2 |
3321 |
0.18 |
chr18_78122352_78123104 | 4.13 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
603 |
0.79 |
chr9_66988141_66989423 | 4.12 |
Gm24225 |
predicted gene, 24225 |
7597 |
0.16 |
chr2_103900802_103900953 | 4.11 |
Gm13881 |
predicted gene 13881 |
11147 |
0.12 |
chr3_98280903_98281615 | 4.11 |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
824 |
0.54 |
chr6_143832506_143833713 | 4.11 |
Sox5 |
SRY (sex determining region Y)-box 5 |
113979 |
0.06 |
chr3_14892484_14892674 | 4.11 |
Car2 |
carbonic anhydrase 2 |
5940 |
0.21 |
chr6_56901300_56901698 | 4.10 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
384 |
0.8 |
chrX_9467805_9468124 | 4.10 |
Cybb |
cytochrome b-245, beta polypeptide |
1305 |
0.48 |
chr2_132574329_132574489 | 4.10 |
Gpcpd1 |
glycerophosphocholine phosphodiesterase 1 |
3724 |
0.2 |
chr15_67173864_67174424 | 4.03 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
2568 |
0.37 |
chr11_116578905_116579575 | 4.02 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
2207 |
0.17 |
chr3_116563532_116563761 | 4.02 |
Lrrc39 |
leucine rich repeat containing 39 |
668 |
0.48 |
chr4_13752540_13753163 | 4.00 |
Runx1t1 |
RUNX1 translocation partner 1 |
1554 |
0.54 |
chr5_58859182_58859333 | 3.98 |
Gm43394 |
predicted gene 43394 |
141736 |
0.05 |
chr1_97658696_97658879 | 3.98 |
AC099860.1 |
proline rich protein BstNI subfamily 4 (PRB4), pseudogene |
2044 |
0.31 |
chr2_173026008_173027110 | 3.98 |
Rbm38 |
RNA binding motif protein 38 |
3509 |
0.16 |
chr5_74064229_74066220 | 3.97 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr12_7978894_7979569 | 3.96 |
Apob |
apolipoprotein B |
1452 |
0.45 |
chr5_129006398_129007001 | 3.96 |
Stx2 |
syntaxin 2 |
1724 |
0.37 |
chr4_24645917_24646115 | 3.96 |
Klhl32 |
kelch-like 32 |
29411 |
0.21 |
chr7_31040855_31042728 | 3.94 |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
48 |
0.93 |
chr7_120979495_120980366 | 3.93 |
Cdr2 |
cerebellar degeneration-related 2 |
1860 |
0.19 |
chr6_34486794_34486963 | 3.91 |
Bpgm |
2,3-bisphosphoglycerate mutase |
9736 |
0.17 |
chr2_35328016_35328727 | 3.90 |
Stom |
stomatin |
7866 |
0.14 |
chr6_40584486_40584709 | 3.89 |
Clec5a |
C-type lectin domain family 5, member a |
1193 |
0.36 |
chr4_43558006_43559275 | 3.88 |
Tln1 |
talin 1 |
180 |
0.86 |
chr9_48362102_48362695 | 3.87 |
Nxpe4 |
neurexophilin and PC-esterase domain family, member 4 |
357 |
0.87 |
chr9_57637252_57639630 | 3.87 |
Csk |
c-src tyrosine kinase |
4374 |
0.13 |
chr7_97749255_97749938 | 3.87 |
Aqp11 |
aquaporin 11 |
11307 |
0.16 |
chr4_104875670_104875994 | 3.86 |
C8a |
complement component 8, alpha polypeptide |
551 |
0.78 |
chr11_84825899_84826527 | 3.86 |
Dhrs11 |
dehydrogenase/reductase (SDR family) member 11 |
2751 |
0.16 |
chr15_27469013_27469455 | 3.86 |
Ank |
progressive ankylosis |
2557 |
0.23 |
chr1_40268022_40268173 | 3.85 |
Il1r1 |
interleukin 1 receptor, type I |
1440 |
0.43 |
chr2_62588440_62588591 | 3.85 |
Fap |
fibroblast activation protein |
14440 |
0.2 |
chr1_36070290_36070622 | 3.84 |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
2056 |
0.25 |
chr3_145591307_145591663 | 3.83 |
Znhit6 |
zinc finger, HIT type 6 |
4383 |
0.23 |
chr7_84688773_84688924 | 3.83 |
2610206C17Rik |
RIKEN cDNA 2610206C17 gene |
792 |
0.47 |
chr1_160990282_160990480 | 3.82 |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
1004 |
0.26 |
chr1_51288641_51290950 | 3.82 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr17_5494452_5495422 | 3.81 |
Zdhhc14 |
zinc finger, DHHC domain containing 14 |
2380 |
0.28 |
chr7_103872542_103872693 | 3.81 |
Olfr66 |
olfactory receptor 66 |
9624 |
0.06 |
chr15_44463989_44464408 | 3.81 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
6645 |
0.18 |
chr9_101995216_101995423 | 3.80 |
Gm31326 |
predicted gene, 31326 |
6059 |
0.2 |
chr1_7980248_7980452 | 3.80 |
Gm38216 |
predicted gene, 38216 |
249785 |
0.02 |
chr3_142884245_142884709 | 3.80 |
9530052C20Rik |
RIKEN cDNA 9530052C20 gene |
1982 |
0.21 |
chr2_10129433_10129753 | 3.80 |
Itih2 |
inter-alpha trypsin inhibitor, heavy chain 2 |
1070 |
0.39 |
chr8_128688078_128688272 | 3.79 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
2305 |
0.29 |
chr15_83565063_83565535 | 3.78 |
Tspo |
translocator protein |
1424 |
0.25 |
chr9_44486015_44488913 | 3.77 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr9_113968662_113968987 | 3.77 |
Ubp1 |
upstream binding protein 1 |
401 |
0.82 |
chr11_58640333_58641440 | 3.77 |
Trim58 |
tripartite motif-containing 58 |
421 |
0.65 |
chr12_103630582_103631271 | 3.76 |
Serpina10 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
495 |
0.69 |
chr2_103958009_103958847 | 3.76 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr17_91484288_91484439 | 3.75 |
Gm49989 |
predicted gene, 49989 |
52227 |
0.12 |
chr11_95344184_95344738 | 3.75 |
Fam117a |
family with sequence similarity 117, member A |
4499 |
0.14 |
chr15_77773473_77773679 | 3.73 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
3797 |
0.14 |
chr10_120112009_120112168 | 3.73 |
Helb |
helicase (DNA) B |
777 |
0.67 |
chr13_98811279_98811494 | 3.72 |
Fcho2 |
FCH domain only 2 |
3767 |
0.15 |
chrX_7964902_7965134 | 3.72 |
Gata1 |
GATA binding protein 1 |
852 |
0.37 |
chr14_65832277_65832465 | 3.71 |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
552 |
0.75 |
chr10_11283698_11283854 | 3.71 |
Fbxo30 |
F-box protein 30 |
2189 |
0.23 |
chr13_101690123_101690666 | 3.71 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
1949 |
0.39 |
chr10_75697240_75697855 | 3.69 |
Cabin1 |
calcineurin binding protein 1 |
2828 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.6 | 10.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
2.6 | 7.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.5 | 7.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.4 | 12.1 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
2.3 | 9.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
2.3 | 4.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.7 | 6.8 | GO:0008228 | opsonization(GO:0008228) |
1.7 | 5.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.6 | 6.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.5 | 4.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.5 | 6.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.5 | 6.1 | GO:0032264 | IMP salvage(GO:0032264) |
1.5 | 4.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.4 | 2.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.3 | 5.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.3 | 6.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.3 | 6.7 | GO:0046618 | drug export(GO:0046618) |
1.3 | 3.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.3 | 2.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.3 | 3.8 | GO:0043366 | beta selection(GO:0043366) |
1.2 | 8.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.1 | 3.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.1 | 10.3 | GO:0097286 | iron ion import(GO:0097286) |
1.1 | 4.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.1 | 3.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.1 | 3.4 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.1 | 3.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.1 | 3.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.0 | 3.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.0 | 3.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.0 | 2.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.0 | 5.0 | GO:0070836 | caveola assembly(GO:0070836) |
1.0 | 3.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.0 | 4.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.0 | 2.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 2.9 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.0 | 2.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.0 | 5.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.0 | 2.9 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.9 | 4.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 2.8 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.9 | 4.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 0.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.9 | 3.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.9 | 4.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.9 | 2.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.8 | 2.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.8 | 6.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.8 | 2.5 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.8 | 6.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.8 | 9.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 2.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.8 | 1.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.8 | 1.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.8 | 3.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.8 | 0.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 6.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.8 | 2.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.8 | 2.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.8 | 2.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.8 | 7.9 | GO:0007379 | segment specification(GO:0007379) |
0.8 | 4.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 2.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.8 | 7.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.8 | 0.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.8 | 4.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.8 | 15.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 2.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.8 | 3.0 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.7 | 3.7 | GO:0002576 | platelet degranulation(GO:0002576) |
0.7 | 2.2 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.7 | 2.2 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 2.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.7 | 4.3 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.7 | 5.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.7 | 4.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 2.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 2.8 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.7 | 4.8 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.7 | 4.8 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.7 | 2.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 2.7 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 1.3 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.7 | 0.7 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.6 | 3.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.6 | 0.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.6 | 0.6 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.6 | 1.9 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.6 | 1.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 2.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.6 | 2.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 0.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.6 | 2.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 1.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.6 | 3.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 0.6 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.6 | 4.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.6 | 1.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 5.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.6 | 3.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.6 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 0.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.6 | 1.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 2.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.6 | 2.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 1.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.6 | 1.7 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.5 | 2.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.5 | 4.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.5 | 1.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 12.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 1.6 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.5 | 0.5 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.5 | 2.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.5 | 1.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.5 | 3.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.5 | 10.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.5 | 1.5 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.5 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 1.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 1.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.5 | 1.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 2.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 4.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 0.5 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 2.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 1.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.5 | 1.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.5 | 3.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 0.5 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.5 | 2.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 1.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 1.4 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.5 | 1.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 0.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 2.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 1.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.5 | 1.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.5 | 6.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 2.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 1.4 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.5 | 1.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 2.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 1.8 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 1.3 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 10.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 1.8 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.4 | 1.3 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.4 | 2.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 0.9 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.4 | 1.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 1.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 1.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 1.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.4 | 1.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 2.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 13.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.4 | 8.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 1.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 1.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 2.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.4 | 1.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 1.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.4 | 2.1 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.4 | 2.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 3.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 2.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 1.6 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.4 | 1.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 2.4 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.4 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.4 | 2.0 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.4 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 0.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 5.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 3.5 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 3.5 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 1.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.4 | 1.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 1.5 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 0.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 1.5 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 1.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 1.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.4 | 1.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 4.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 1.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 1.9 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.4 | 1.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.4 | 1.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.4 | 1.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 0.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 1.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.4 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 5.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 1.1 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.4 | 1.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 6.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.4 | 1.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.3 | 0.3 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.3 | 0.7 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 1.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 6.9 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 0.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.3 | 1.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 1.7 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.3 | 1.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 8.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 1.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 2.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 2.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.7 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 1.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 1.0 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.3 | 1.0 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 0.6 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.3 | 1.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 1.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.6 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 1.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 1.0 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 0.6 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.3 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 1.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 0.6 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.3 | 0.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.3 | 1.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 0.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 14.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.6 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.3 | 1.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 3.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.3 | 0.9 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 2.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.3 | 0.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 0.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 0.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 1.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 0.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 2.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) |
0.3 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 1.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 1.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 0.9 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 2.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 0.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 7.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 3.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.9 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.3 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 3.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 3.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.3 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 1.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 3.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 2.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 3.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.8 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 3.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 0.6 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 1.4 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.4 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.3 | 1.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 0.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 2.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 0.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 0.3 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.3 | 0.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 1.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 0.5 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.3 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 1.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.8 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.3 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.8 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 1.3 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.3 | 0.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.3 | 0.3 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.3 | 0.5 | GO:0042119 | neutrophil activation(GO:0042119) |
0.3 | 0.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.3 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 3.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 1.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.3 | 0.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 2.6 | GO:0002190 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
0.3 | 0.8 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 3.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 5.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 2.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 4.0 | GO:0033363 | secretory granule organization(GO:0033363) |
0.3 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 1.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 5.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 1.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 1.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 1.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 0.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.5 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 1.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 4.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.2 | 1.9 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 1.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 1.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 1.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.7 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 3.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 2.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 1.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 1.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 0.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.7 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.2 | 5.4 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 3.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.2 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.4 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 0.4 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 1.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.7 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.7 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.2 | GO:0002524 | hypersensitivity(GO:0002524) |
0.2 | 0.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 1.7 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 1.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 5.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.4 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.6 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 2.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.8 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.6 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 1.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 2.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.8 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.6 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 1.0 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.4 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.2 | 1.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 1.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.6 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 5.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 1.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 2.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 4.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.8 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 2.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 3.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.2 | GO:0045472 | response to ether(GO:0045472) |
0.2 | 0.2 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.2 | 0.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 1.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.2 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 2.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.1 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 0.4 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.2 | 4.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.7 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.2 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 2.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 1.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 1.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.9 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.5 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.2 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.2 | 3.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 1.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.3 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 2.6 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.2 | 4.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 2.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.7 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 3.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 1.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 1.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.2 | 1.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 0.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 2.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 1.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.5 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 2.0 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.3 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.2 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 1.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.2 | 13.0 | GO:0007599 | hemostasis(GO:0007599) |
0.2 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.3 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 2.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 3.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.2 | 0.9 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.8 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.6 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.2 | GO:0043217 | myelin maintenance(GO:0043217) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 0.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 1.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 2.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.2 | 0.8 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 0.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.8 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.2 | 0.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.2 | 1.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 1.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.3 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.2 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.2 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.2 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 1.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 1.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:1901563 | response to camptothecin(GO:1901563) |
0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 1.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 2.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 4.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 0.6 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.1 | 1.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 1.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 1.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 1.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 3.7 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:1904751 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 1.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.4 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 1.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.8 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 1.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.4 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 1.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 1.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.9 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 1.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 1.9 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 4.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.2 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 1.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.7 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
0.1 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 1.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 3.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 2.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.2 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 1.7 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
0.1 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 3.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.1 | 0.2 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.1 | 0.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 3.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.6 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 1.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.8 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.1 | 3.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 9.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.3 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.3 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.5 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.4 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 2.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0052805 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 1.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 2.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.8 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.4 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.1 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.3 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 1.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.2 | GO:1903332 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
0.1 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 4.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.1 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.1 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.6 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 0.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.1 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0033033 | regulation of myeloid cell apoptotic process(GO:0033032) negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.4 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.3 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 2.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 1.8 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.2 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 2.6 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.1 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 1.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.1 | 0.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.3 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.1 | 1.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.1 | 0.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.1 | 1.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.1 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.2 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.2 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 0.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.3 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0019076 | viral release from host cell(GO:0019076) |
0.1 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.8 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 2.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:0036166 | phenotypic switching(GO:0036166) |
0.1 | 0.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 1.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 2.4 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 2.5 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.1 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.1 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.3 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.4 | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.0 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.0 | 3.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.0 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.5 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.0 | 0.0 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 1.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.8 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 1.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.0 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.3 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.2 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.0 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.3 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.0 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.0 | 0.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.0 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.0 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.0 | 0.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.0 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.0 | 0.0 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.2 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 1.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0006497 | protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
0.0 | 1.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.4 | GO:0060143 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.2 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.3 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.0 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.0 | 0.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.8 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.0 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.0 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.0 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.0 | 0.5 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 17.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:1902074 | response to salt(GO:1902074) |
0.0 | 0.0 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.0 | 0.0 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.0 | 0.1 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.0 | 0.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 10.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.0 | 5.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.6 | 8.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.1 | 6.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.1 | 5.5 | GO:0005579 | membrane attack complex(GO:0005579) |
1.0 | 3.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.0 | 4.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 6.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 2.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.9 | 4.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.9 | 9.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 2.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.8 | 2.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 3.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.8 | 3.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.8 | 5.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 2.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 6.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 1.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 2.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 3.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) nuclear meiotic cohesin complex(GO:0034991) |
0.6 | 1.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 1.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 3.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 4.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 2.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 0.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.5 | 1.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 3.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 4.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 2.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 3.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 1.5 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 0.5 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.5 | 16.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 7.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 2.8 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 1.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.3 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 2.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 1.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 11.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 11.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 4.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.4 | 2.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 2.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 2.4 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 1.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 1.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 2.3 | GO:0005818 | aster(GO:0005818) |
0.4 | 4.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 1.9 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 3.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 4.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 4.7 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 2.1 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 3.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 30.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 4.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 1.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 3.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 3.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.0 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 1.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 7.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 2.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 3.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 2.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 0.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.3 | 1.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 1.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 3.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 0.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 3.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 2.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 1.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.2 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.6 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 2.3 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 4.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.7 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 5.5 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 1.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 2.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 1.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 2.0 | GO:0002102 | podosome(GO:0002102) |
0.2 | 3.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 0.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 2.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 2.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 7.8 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 1.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 2.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 2.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 2.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 2.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 6.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 7.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 3.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 1.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 6.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 2.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.9 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 2.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.3 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 3.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 6.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 4.1 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.1 | 4.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 3.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 2.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 2.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 3.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 2.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 40.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 9.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 2.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 5.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 2.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 1.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 8.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 6.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 3.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 5.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 1.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 8.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 4.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 8.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 1.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 94.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 12.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 5.7 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 5.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 4.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 16.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0043230 | extracellular organelle(GO:0043230) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.5 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 5.9 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.9 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 4.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.9 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 0.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 6.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 3.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 2.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 4.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 1.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 6.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 2.4 | GO:0031975 | envelope(GO:0031975) |
0.0 | 0.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 1.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.4 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 2.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 49.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.5 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.1 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 7.2 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0044440 | endosomal part(GO:0044440) |
0.0 | 13.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 8.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 1.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0033269 | internode region of axon(GO:0033269) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.7 | 10.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.0 | 8.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.9 | 5.8 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.9 | 5.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.7 | 6.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.6 | 11.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.5 | 6.2 | GO:0015265 | urea channel activity(GO:0015265) |
1.4 | 4.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.3 | 4.0 | GO:0004064 | arylesterase activity(GO:0004064) |
1.2 | 3.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.2 | 4.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.2 | 3.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.1 | 5.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.1 | 3.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.1 | 4.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.0 | 3.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.0 | 6.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.0 | 3.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.0 | 2.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.0 | 8.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.0 | 5.7 | GO:0035473 | lipase binding(GO:0035473) |
0.9 | 6.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.9 | 2.8 | GO:0035877 | death effector domain binding(GO:0035877) |
0.9 | 3.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.9 | 2.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.9 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.8 | 2.5 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 4.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 2.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.8 | 2.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 0.7 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.7 | 5.9 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.7 | 4.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 2.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 8.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 5.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 3.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 1.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.7 | 2.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 5.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 0.7 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.7 | 2.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 2.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.7 | 2.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 2.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.6 | 2.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 1.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 1.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 3.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 4.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 2.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.6 | 2.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 7.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 2.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.6 | 2.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 1.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 1.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 2.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 2.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.5 | 8.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 2.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 3.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 1.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 2.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 4.4 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.5 | 2.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 4.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 1.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 7.1 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 2.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 1.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.5 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.5 | 2.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 6.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 1.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 2.2 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 2.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 2.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 8.2 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 1.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 2.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 9.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 1.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 3.4 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 3.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 1.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 4.6 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 1.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 3.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 5.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 3.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 2.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.4 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 1.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 1.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 1.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 1.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 3.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 2.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 3.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 2.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 8.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 2.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 2.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 3.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 3.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 5.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.9 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 0.9 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 2.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 2.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 5.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.3 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.3 | 1.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 0.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 1.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 8.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 1.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 4.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 3.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 6.4 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 4.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 2.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 2.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 1.0 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 3.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 1.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 1.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.7 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 6.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 7.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 6.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 1.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 4.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 2.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 1.8 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.2 | 25.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 2.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 1.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 4.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 1.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 1.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 1.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.9 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.2 | 2.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 6.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.3 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 1.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 5.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 1.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 6.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 3.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.8 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 1.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 2.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 2.1 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 1.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 2.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 2.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 5.8 | GO:0080030 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 8.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 1.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.5 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.9 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 0.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 2.1 | GO:0004787 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.2 | 0.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 3.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.2 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 1.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 2.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 1.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 3.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 6.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 1.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 1.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 25.7 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 1.1 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 13.7 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.2 | 1.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 1.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.0 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 6.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 12.9 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.0 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 3.1 | GO:0048258 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 1.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 4.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 3.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.5 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 1.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 2.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 1.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.9 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 1.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.2 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 2.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 3.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 3.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 5.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 2.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 2.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 1.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 7.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 4.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.7 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 4.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.6 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 5.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 18.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 4.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 6.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 5.7 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 3.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 4.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 6.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.9 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 7.2 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 2.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 3.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 1.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 1.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 1.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 1.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.5 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 1.5 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 5.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 13.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.1 | 1.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.1 | GO:0070568 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.8 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 2.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 2.9 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 13.4 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.4 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 6.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 3.0 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 6.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.3 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.1 | GO:0005416 | sodium:amino acid symporter activity(GO:0005283) cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 3.1 | GO:0048037 | cofactor binding(GO:0048037) |
0.0 | 1.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 1.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 1.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 2.0 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 1.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 2.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.3 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) cyclohydrolase activity(GO:0019238) N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.6 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 11.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.4 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 19.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 24.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 14.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 5.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 18.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 3.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 6.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 3.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 9.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 5.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 12.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 8.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 4.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 2.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 4.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 5.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 7.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 6.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 6.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 2.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 4.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 1.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 6.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 3.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 5.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 5.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 10.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 5.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 6.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 5.5 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 1.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 2.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 12.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 6.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.1 | 11.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 13.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 10.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.9 | 6.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.8 | 10.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 7.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 8.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 7.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 5.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 9.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.6 | 11.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 11.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.5 | 9.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 6.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 6.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 11.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 10.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.5 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 4.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 3.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.5 | 3.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 7.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 6.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 5.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 2.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 2.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.4 | 1.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 3.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 0.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.4 | 3.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 2.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 6.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 8.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 1.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 1.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 3.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 1.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.3 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 6.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 2.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 6.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 7.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 5.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 5.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 0.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 11.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 1.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 1.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 6.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 5.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 14.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 4.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 1.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 3.7 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 2.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 3.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 1.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 2.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 6.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 2.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 5.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 4.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 7.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 0.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 2.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 1.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 3.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 7.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 4.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 12.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 8.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 4.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 3.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 7.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 2.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 9.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 2.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 12.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 1.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 3.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 3.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 4.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 3.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 10.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 2.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 2.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 4.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.6 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 1.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 2.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 2.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 1.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 2.4 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |